Podcast Episodes
Back to SearchNetskope Plummets 20% — The Post-IPO Reality Check or a Cybersecurity Steal?
Season 1 Episode 112
Netskope just saw its valuation chopped by 20% in a pre-market tailspin, despite reporting 32% revenue growth and hitting a major milestone: its firs…
8 months ago
FICO Plunges 9% to New Lows — Is the Credit King’s Moat Drying Up?
Season 1 Episode 111
Fair Isaac Corporation (FICO) just hit a fresh 52-week low, dropping 9% in a single session as a double-whammy of debt and competition rocks the cred…
8 months ago
CRISPR Therapeutics Slides 9% After $500M Debt Surprise — The Cost of Curing Disease?
Season 1 Episode 110
CRISPR Therapeutics just took a 9% gut punch, gapping down to $54 after a sudden announcement caught investors off guard. The culprit? It wasn’t a fa…
8 months ago
JFrog Plummets 7.2% as GitLab’s Warning Sparks a DevOps Bloodbath
Season 1 Episode 109
JFrog (FROG) just got caught in a brutal industry sell-off, sliding 7.2% to close at $39.19. Despite a massive $300 million buyback program and cloud…
8 months, 1 week ago
Sea Limited Craters 16% — The High Cost of Defending a Kingdom
Season 1 Episode 108
Sea Limited just experienced a brutal 16% wipeout in a single session, proving that in 2026, revenue growth isn't enough to satisfy a hungry Wall Str…
8 months, 1 week ago
e.l.f. Beauty Slides 11% Despite Earnings Blowout — Perfection Isn't Enough for Wall Street
Season 1 Episode 107
e.l.f. Beauty just posted a massive 77% earnings beat and its 28th consecutive quarter of market share gains, yet the stock is tumbling over 11%. Why…
8 months, 1 week ago
Diageo’s 15% Hangover — The End of the Luxury Booze Boom?
Season 1 Episode 106
Diageo, the powerhouse behind Johnnie Walker and Don Julio, just saw its stock price stumble 15% after a brutal reality check. The "premiumization" t…
8 months, 2 weeks ago
Novo Nordisk Craters 16% — The End of the GLP-1 Monopoly?
Season 1 Episode 105
Novo Nordisk just suffered a staggering 16% collapse, wiping out nearly the entire "Wegovy era" of gains in a single day. The "miracle" drug maker wa…
8 months, 3 weeks ago
Madrigal Pharmaceuticals Plunges 11% — A Billion-Dollar Hit or a Biotech Trap?
Season 1 Episode 104
Madrigal Pharmaceuticals just watched its stock price fall off a cliff, dropping over 11% in a single morning despite reporting a staggering 210% rev…
8 months, 3 weeks ago
Palo Alto Networks Craters 8% — The Cost of Building a Cybersecurity Fortress
Season 1 Episode 103
Palo Alto Networks just watched its stock price crater 8% in a single session, despite beating expectations on both the top and bottom lines. Why the…
8 months, 3 weeks ago